首页> 外文期刊>Journal of clinical nursing >Anaemia management protocols in the care of haemodialysis patients: Examining patient outcomes
【24h】

Anaemia management protocols in the care of haemodialysis patients: Examining patient outcomes

机译:血液透析患者护理中的贫血管理方案:检查患者预后

获取原文
获取原文并翻译 | 示例
           

摘要

Aims and objectives: To determine whether the use of a nurse-driven protocol in the haemodialysis setting is as safe and effective as traditional physician-driven approaches to anaemia management. Background: The role of haemodialysis nurses in renal anaemia management has evolved through the implementation of nurse-driven protocols, addressing the trend of exceeding haemoglobin targets and rising costs of erythropoietin-stimulating agents. Design: Retrospective, non-equivalent case control group design. Methods: The sample was from three haemodialysis units in a control group (n = 64) and three haemodialysis units in a protocol group (n = 43). The protocol group used a nurse-driven renal anaemia management protocol, while the control group used a traditional physician-driven approach to renal anaemia management. All retrospective data were obtained from a provincial renal database. Data were analysed using chi-square tests and t-tests. Patient outcomes examined were haemoglobin levels, transferrin saturation levels, erythropoietin-stimulating agents use and intravenous iron use. Cost comparisons were determined using average use of erythropoietin-stimulating agents and intravenous iron. Results: Control and protocol groups reached haemoglobin target levels. In the protocol group, 75% reached transferrin saturation target levels in comparison with 25% of the control group. Use and costs for iron was higher in the control group, while use and costs for erythropoietin was higher in the protocol group. The higher usage of erythropoietin-stimulating agents was potentially related to comorbid conditions amongst the protocol group. Conclusions: A nurse-driven protocol approach to renal anaemia management was as effective as the physician-driven approach in reaching haemoglobin and transferrin saturation levels. Further examination of the use and dosing of erythropoietin-stimulating agents and intravenous iron, their impact on haemoglobin levels related to patient comorbidities and subsequent cost effectiveness of protocols is required. Relevance to clinical practice: Using a nurse-driven protocol in practice supports the independent nursing role while contributing to safe patient outcomes.
机译:目的和目标:确定在血液透析环境中使用护士驱动的方案是否与传统的医生驱动的贫血管理方法一样安全有效。背景:血液透析护士在肾性贫血管理中的作用已通过实施护士驱动的方案而得到发展,解决了血红蛋白指标超标和促红细胞生成素刺激剂成本上升的趋势。设计:回顾性,非等效病例对照组设计。方法:样本来自对照组的三个血液透析单位(n = 64)和方案组的三个血液透析单位(n = 43)。方案组使用护士驱动的肾性贫血管理方案,而对照组则使用传统的医生驱动的肾性贫血管理方案。所有回顾性数据均来自省肾脏数据库。使用卡方检验和t检验分析数据。检查的患者预后为血红蛋白水平,转铁蛋白饱和度水平,促红细胞生成素刺激剂的使用和静脉铁剂的使用。成本比较是通过平均使用促红细胞生成素刺激剂和静脉注射铁剂来确定的。结果:对照组和方案组均达到血红蛋白目标水平。在方案组中,与对照组的25%相比,有75%达到了转铁蛋白饱和目标水平。对照组中铁的使用和成本较高,而协议组中的促红细胞生成素的使用和成本较高。促红细胞生成素刺激剂的较高使用量可能与协议组中的合并症有关。结论:在肾血红蛋白和转铁蛋白饱和度水平达到水平时,护士驱动的方案可与医生驱动的方案一样有效。需要进一步检查促红细胞生成素刺激剂和静脉内铁剂的使用和剂量,它们对与患者合并症相关的血红蛋白水平的影响以及方案的后续成本效益。与临床实践的相关性:在实践中使用护士驱动的方案可支持独立的护理角色,同时有助于确保患者的安全结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号